AVY
53
3
NUE
51
3
ETR
66
3
HRL
30
3
STX
53
3
NTRS
54
4
YUM
43
5
AMP
66
3
DG
27
-2
AMGN
42
-5
PFE
21
-2
ADI
45
-2
DRI
47
4
PX
66
4
MTCH
53
3
V
56
2
SLB
45
4
BEN
34
6
PEP
47
2
HRB
56
2
AVY
53
3
NUE
51
3
ETR
66
3
HRL
30
3
STX
53
3
NTRS
54
4
YUM
43
5
AMP
66
3
DG
27
-2
AMGN
42
-5
PFE
21
-2
ADI
45
-2
DRI
47
4
PX
66
4
MTCH
53
3
V
56
2
SLB
45
4
BEN
34
6
PEP
47
2
HRB
56
2
Financhill
Back

NeueHealth 10K Form

Sell
23

NEUE
NeueHealth

Last Price:
4.97
Seasonality Move:
5.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NEUE News And Ratings

See the #1 stock for the next 7 days that we like better than NEUE

NEUE Financial Statistics

Sales & Book Value

Annual Sales: $1.16B
Cash Flow: $-29.24M
Price / Cash Flow: 0
Annual Sales: $-157.84
Price / Book: 0

Profitability

EPS (TTM): -123.68000
Net Income (TTM): $-938.16M
Gross Margin: $164.22M
Return on Equity: -3241.93%
Return on Assets: -48.48%

NeueHealth Earnings Forecast

Key NeueHealth Financial Ratios

  • The Gross Profit Margin over the past 6 years for NEUE is 14.15%.
  • The Selling, General & Administrative Expenses for NEUE have been equal to 22.33% of Gross Profit Margin.
  • The Research & Development expenses have been 1.95% of Revenue.
  • The Interest Expense is -3.32% of Operating Income.
  • The Net Earning history of NEUE is -99.19% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

NeueHealth Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: NEUE
Website: neuehealth.com

Debt

Debt-to-Equity Ratio: -0.3
Current Ratio: 0.75
Quick Ratio: 0.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NEUE Technical Analysis vs Fundamental Analysis

Sell
23
NeueHealth (NEUE) is a Sell

Is NeueHealth a Buy or a Sell?

  • NeueHealth stock is rated a Sell
    The current NeueHealth [NEUE] share price is $4.94. The Score for NEUE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.